Effect of Docosahexaenoic Acid on Rate of Differentiation of HL-60 Human Leukemia

Cancer Research

Volumn 49, Issue 12, 1989, Pages 3252-3258

  Burns, C Patrick ^a   Petersen, Eric S ^a   North, James A ^a   Ingraham, Leah M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; RETINOIC ACID;

CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS; HUMAN; KINETICS; LEUKEMIA, PROMYELOCYTIC, ACUTE; PHOSPHOLIPIDS; SUPEROXIDES; SUPPORT, U.S. GOV'T, P.H.S.; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0024328821     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Nakayasu, M., Terada, M., Tamura, G., and Sugimura, T. Induction of differentiation of human and murine myeloid leukemia cells in culture by tunicamycin. Proc. Natl. Acad. Sci. USA, 77:409–413,1980.
2. Collins, S. J. The HL-60 promyelocyte leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood, 70: 1233–1244, 1987.
3. Lyman, G. H., Preisler, H. D., and Papahadjopoulos, D. Membrane action of DMSO and other chemical inducers of Friend leukaemic cell differentiation. Nature (Lond.), 262:360–363,1976.
4. Preisler, H. D., Christoff, G., and Taylor, E. Cryoprotective agents as inducers of erythroleukemic cell differentiation in vitro. Blood, 47:363–368, 1976.
5. Cooper, R. A., Braunwald, A. D., and Kuo, A. L. Phorbol ester induction of leukemic cell differentiation is a membrane-mediated process. Proc. Natl. Acad. Sci. USA, 79:2865–2869,1982.
6. McPhail, L. C., Clayton, C. C., and Snyderman, R. A potential second messenger role for unsaturated fatty acids: activation of Ca2+-dependent protein kinase. Science (Wash. DC), 224:622–625, 1984.
7. Boyd, A. W., and Metcalf, D. Induction of differentiation in HL-60 leukaemic cells: a cell cycle dependent all-or-none event. Leuk. Res., 8:27–43, 1984.
8. Leder, A., and Leder, P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell, 5: 319–322,1975.
9. Takeda, K., Minowada, J., and Bloch, A. Kinetics of appearance of differentiation-associated characteristics in ML-1, a line of human myeloblasts leukemia cells, after treatment with 12-O-tetradecanoylphorbol-13-acetate, dimethyl sulfoxide, or 1-β-D-arabinofuranosylcytosine. Cancer Res., 42: 5152–5158,1982.
10. Friend, C., Scher, W., Holland, J. G., and Sato, T. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc. Natl. Acad. Sci. USA, 68: 378–382, 1971.
11. Lotem, J., and Sachs, L. Genetic dissection of the control of normal differentiation in myeloid leukemic cells. Proc. Natl. Acad. Sci. USA, 74: 5554- 5558.1977.
12. Gallagher, R., Collins, S., Trujillo, J., McCredie, K., Ahearn, M., Tsai, S., Metzgar, R., Aulakh, G., Ting, R., Ruscetti, F., and Gallo, R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytk leukemia. Blood, 54:713–733,1979.
13. Collins, S. J., Ruscetti, F. W., Gallagher, R. E., and Gallo, R. C. Terminal differentiation of human promyelocytk leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA, 75:2458- 2462.1978.
14. Dalton, W. T., Jr., Ahearn, M. J., McCredie, K. B., Freireich, E. J., Stass, S. A., and Trujillo, J. M. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood, 71:242–247,1988.
15. Yen, A. Control of HL-60 myeloid differentiation. Evidence of uncoupled growth and differentiation control, S-phase specificity, and two-step regulation. Exp. Cell Res., 156:198–212,1985.
16. Langdon, S. P., and Hickman, J. A. Correlation between molecular weight and potency of polar compounds which induce the differentiation of HL-60 human promyelocyte leukemia cells. Cancer Res., 47:140–144,1987.
17. Guffy, M. M., North, J. A., and Burns, C. P. Effect of cellular fatty acid alteration on Adriamycin sensitivity in cultured LI210 murine leukemia cells. Cancer Res., 44:1863–1866,1984.
18. Folch, J., Lees, M., and Sloane Stanley, G. H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226:497–509,1957.
19. Burns, C. P., Luttenegger, D. G., Wei, S. L., and Spector, A. A. Modification of the fatty acid composition of LI210 murine leukemia cells. Lipids, 12: 747–752,1977.
20. Morrison, W. R., and Smith, L. M. Preparation of fatty acid methyl esters and dimethylacetals from lipids and boron fluoride-methanol. J. Lipid Res., 5:600–608,1964.
21. Breitman, T. R., Selonick, S. E., and Collins, S. J. Induction of differentiation in the human promyelocytk: leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA, 77:2936–2940,1980.
22. Yen, A., Reece, S. L., and Albright, K. L. Dependence of HL-60 myeloid cell differentiation on continuous and split retinoic acid exposures: precommitment memory associated with altered nuclear structure. J. Cell. Physiol., 118:277–286, 1984.
23. Babior, B. M., Kipnes, R. S., and Curnutte, J. T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest., 52:741–744,1973.
24. Mendelsohn, N., Gilbert, H. S., Christman, J. K., and Acs, G. Effect of maturation on the response of human promyelocytk leukemia cells (HL-60) to the tumor promoter 12–0-tetradecanoylphorbol-13-acetate. Cancer Res., 40:1469–1474, 1980.
25. Yen, A., Van Sant, R., Harvey, J., and Fishbaugh, J. Myeloid differentiation-inducing factors produced by pokeweed mitogen-treated normal G1/o lymphocytes but not chronic lymphocytic leukemia cells. Cancer Res., 45:4060–4066, 1985.
26. Yen, A., and Stein, L. S. Polyclonal mitogenesis of human lymphocytes by PWM: two preprogrammed division cycles resulting in cells refractile to further mitogenesis. Cell. Immunol., 57:440–454,1981.
27. Yen, A., Reece, S. L., and Albright, K. L. Control of cell differentiation during proliferation—II. Myeloid differentiation and cell cycle arrest of HL-60 promyelocytes preceded by nuclear structural changes. Leuk. Res., 9:51–71,1985.
28. Fried, J., Perez, A. G., and Clarkson, B. D. Flow cytofluorometric analysis of cell cycle distributions using propidium iodide: properties of the method and mathematical analysis of the data. J. Cell Biol., 71:172–181,1976.
29. Guffy, M. M., Rosenberger, J. A., Simon, I., and Burns, C. P. Effect of cellular fatty acid alteration on hyperthermic sensitivity in cultured LI210 murine leukemia cells. Cancer Res., 42:3625–3630,1982.
30. Burns, C. P., and Spector, A. A. Membrane fatty acid modification in tumor cells: a potential therapeutic adjunct. Lipids, 22:178–184,1987.
31. Spector, A. A., and Burns, C. P. Biological and therapeutic potential of membrane lipid modification in tumors. Cancer Res., 47:4529–4537,1987.
32. Burns, C. P., North, J. A., Mossman, C. J., and Ingraham, L. M. Modification of the fatty acid composition of LI210 leukemia subcellular organelles. Lipids, 23:615–618,1988.
33. Yen, A., Reece, S. L., and Albright, K. L. Membrane origin for a signal eliciting a program of cell differentiation. Exp. Cell Res., 152: 493–499, 1984.
34. Sani, B. P., Allen, R. D., Moorer, C. M., and McGee, B. W. Interference of retinoic acid binding to its binding protein by ω-6 fatty acids. Biochem. Biophys. Res. Commun., 147:25–30, 1987.
35. Douer, D., and Koefller, H. P. Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. J. Clin. Invest., 69:277–283,1982.
36. King, M. E., and Spector, A. A. Effect of specific fatty acyl enrichments on membrane physical properties detected with a spin label probe. J. Biol. Chem., 253:6493–6501,1978.
37. Burns, C. P., Luttenegger, D. G., Dudley, D. T., Buettner, G. R., and Spector, A. A. Effect of modification of plasma membrane fatty acid composition on fluidity and methotrexate transport in LI210 murine leukemia cells. Cancer Res.,39:1726–1732,1979.
38. Yen, A., and Guernsey, D. L. Increased c-myc RNA levels associated with the precommitment state during HL-60 myeloid differentiation. Cancer Res., 46:4156–4161,1986.
39. Yen, A., Powers, V., and Fishbaugh, J. Retinoic acid induced HL-60 myeloid differentiation: dependence of early and late events on isomeric structure. Leuk. Res., 70:619–629, 1986.
40. Yen, A., Forbes, M., DeGala, G., and Fishbaugh, J. Control of HL-60 cell differentiation lineage specificity, a late event occurring after precommitment. Cancer Res., 47:129–134,1987.
41. Yen, A., Brown, D., and Fishbaugh, J. Precommitment states induced during HL-60 myeloid differentiation: possible similarities of retinoic acid- and DMSO-induced early events. Exp. Cell Res., 173:80–84,1987.
42. Yen, A., Freeman, L., and Fishbaugh, J. Hydroxyurea induces precommitment during retinoic induced HL-60 terminal myeloid differentiation: possible involvement of gene amplification. Leuk. Res., 11:63–71,1987.
43. Yen, A., Freeman, L., and Fishbaugh, J. Induction of HL-60 monocytic cell differentiation promoted by a perturbation of DNA synthesis: hydroxyurea promotes action of TPA. Exp. Cell Res., 174:98–106,1988.
44. Yen, A., Forbes, M., Galles, M., and Fishbaugh, J. Initiation of HL-60 cell terminal differentiation by bromo-deoxyuridine induced early events causing pre-commitment. Abstracts, Third Conference on Differentiation Therapy, Ares Serono Symposia, p. 102, 1988.
45. Bloch, A. Induced cell differentiation in cancer therapy. Cancer Treat. Rep., 68:199–205,1984.
46. Honma, Y., Honma, C., and Bloch, A. Mechanism of interaction between antineoplastic agents and natural differentiation factors in the induction of human leukemic cell maturation. Cancer Res., 46:6311–6315,1986.
47. Ishikura, H., Honma, Y., Honma, C., Hozumi, M., Black, J. D., Kieber-Emmons, T., and Bloch, A. Inhibition of messenger RNA transcriptional activity in ML-1 human myeloblastic leukemia cell nuclei by antiserum to a c-myb-specific peptide. Cancer Res., 47:1052–1057,1987.
48. Ruscetti, F. W., Collins, S. J., Woods, A. M., and Gallo, R. C. Clonal analysis of the response of human myeloid leukemic cell lines to colony-stimulating activity. Blood, 58:285–292,1981.
49. Metcalf, D. Clonal analysis of the response of HL-60 human myeloid leukemia cells to biological regulators. Leuk. Res., 7:117–132,1983.
50. Brennan, J. K., Abboud, C. N., DiPersio, J. F., Barlow, G. H., and Lichtman, M. A. Autostimulation of growth by human myelogenous leukemia cells (HL-60). Blood, 58:803–812,1981.
51. Perkins, S. L., Andreotti, P. E., Sinha, S. K., Wu, M-C., and Yunis, A. A. Human myeloid leukemic cell (HL-60) autostimulaton relationship to colony-stimulating factor. Cancer Res., 44:5169–5175,1984.
52. Braden, L. M., and Carroll, K. K. Dietary polyunsaturated fat in relation to mammary carcinogenesis in rats. Lipids, 21:285–288,1986.
53. Carroll, K. K., and Braden, L. M. Dietary fat and mammary carcinogenesis. Nutr. Cancer, 6:254–259,1985.
54. Jurkowski, J. J., and Cave, W. T., Jr. Dietary effects of menhaden oil on the growth and membrane lipid composition of rat mammary tumors. J. Natl. Cancer Inst., 74:1145–1150,1985.
55. O’Connor, T. P., Roebuck, B. D., Peterson, F., and Campbell, T. C. Effect of dietary intake offish oil and fish protein on the development of L-azaserine-induced preneoplastic lesions in the rat pancreas. J. Natl. Cancer Inst., 75: 959–962,1985.
56. Reddy, B. S., and Maruyama, H. Effect of dietary fish oil on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res., 46:3367–3370, 1986.
57. Koefller, H. P. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood, 62:709–721,1983.
58. Sartorelli, A. C. Malignant cell differentiation as a potential therapeutic approach. Br. J. Cancer, 52:293–302,1985.
59. Reiss, M., Gamba-Vitalo, C., and Sartorelli, A. C. Induction of tumor cell differentiation as a therapeutic approach: preclinical models for hematopoietic and solid neoplasms. Cancer Treat. Rep., 70:201–218,1986.